Aurobino receives FDA nod for generic hypertension drug
Aurobindo Pharma has received approval from the FDA for Fosinopril Sodium and hydrochlorothiazide (HCT) tablets, a generic equivalent of Bristol-Myers Squibb's ACE inhibitor Monopril HCT.
The Hyderabad, India-based company said its Fosinopril Sodium and HCT Tablets USP 10/12.5mg and 20/12.5mg is the generic equivalent to Monopril HCT tablets 10/12.5mg and 20/12.5mg of Bristol-Myers. Fosinopril Sodium and HCT Tablets are indicated for hypertension and fall under the cardiovascular system therapeutic segment. Aurobindo said it will launch the product shortly in the U.S.
The Hyderabad, India-based company said its Fosinopril Sodium and HCT Tablets USP 10/12.5mg and 20/12.5mg is the generic equivalent to Monopril HCT tablets 10/12.5mg and 20/12.5mg of Bristol-Myers. Fosinopril Sodium and HCT Tablets are indicated for hypertension and fall under the cardiovascular system therapeutic segment. Aurobindo said it will launch the product shortly in the U.S.